Safety profile of clarithromycin in broilers after repeated oral administration

  • Abstract
  • Keywords
  • References
  • PDF
  • Abstract

    The effects of repeated oral administration of clarithromycin (7.5 mg/Kg B.W., daily for 5 consecutive days) on blood parameters, clinico-chemical parameters and vital organ histology were evaluated in Ross broiler chickens. Twelve clinically healthy birds have been used in a parallel study design, where they have been randomly divided into two groups. The 1st group received a dose of 7.5 mg clarithromycin/Kg as intracrop bolus daily for 5 consecutive days after 6 h fasting; while the 2nd group received iso-saline and was kept as control. Blood samples were collected from all birds via the wing and metatarsal vein punctures on the 5th day for clinico-chemical and haematological examinations; and liver, kidneys and heart were dissected out for histopathological examination. Results revealed that repeated administration of clarithromycin caused significant increases in ALP, AST, ALT, CK, urea and creatinine levels, compared to those of control. Metabolic parameters exhibited significant decrease in albumin with consequent decrease in total protein and decreased albumin/globulin ratio. Lipid parameters remained unchanged, compared to control. Leuckogram revealed that total leuckocytic count was decreased as a result of the decreased number of lymphocytes and mid-sized cells. On the other hand, granulocytes number exhibited significant increase (granulocytosis) together with increased number of platelets (thrombocytosis); while erythrogram remained insignifi-cantly affected. Liver and kidney showed inflammatory cellular infiltrations associated with degenerative changes and haemorrhages. Although heart did not show inflammatory cellular infiltrations, yet breakage in some bundles was noted. These data indicate that although clarithromycin did not cause any clinical serious manifestations on the treated birds, yet laboratory analysis revealed some adverse effects on some organs as liver, kidney and heart as well as alterations in some clinic-chemical and hematological parameters; these findings should be taken in consideration during therapy with clarithromycin.

  • Keywords

    Broiler Chicken; Clarithromycin; Pharmacovigilance; Safety.

  • References

      [1] Allain CC, Poon LS, Chan CS, Richmond W & Fu PC (1974), Enzymatic determination of total serum cholesterol. Clinical Chemistry 20, 470-475.

      [2] Alvarez-Elcoro S & Enzler MJ (1999), the macrolides: erythromycin, clarithromycin, and azithromycin. In: Mayo Clinic Proceedings: Elsevier. P 613-634.

      [3] AwadAllah H, Awidat S & El-Mahmoudy A (2016), Pharmacokinetics of clarithromycin after single intravenous and intracrop bolus administrations to broiler chickens. International Journal of Pharmacology and Toxicology 4, 12-18.

      [4] Bancroft JD & Gamble M (2008), Theory and practice of histological techniques: Elsevier Health Sciences.

      [5] Bartels H, Böhmer M & Heierli C (1972), Serum creatinine determination without protein precipitation. Clinica Chimica Acta 37, 193.

      [6] Bergmeyer H, Herder M & Ref R (1986), International Federation of Clinical Chemistry (IFCC). J Clin Chem Clin Biochem 24, 497-510.

      [7] Bessey O, Oliver H & Jane M (1946), A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum. Journal of Biological Chemistry 164, 321-329.

      [8] Black HR, Quallich H & Gareleck CB (1986), racial differences in serum creatine kinase levels. The American Journal of Medicine 81, 479-487.

      [9] Clubb SL, Schubot RM, Joyner K, Zinkl JG, Wolf S, Escobar J, Clubb KJ & Kabbur MB (1990), Hematologic and serum biochemical reference intervals in juvenile eclectus parrots (Eclectus roratus). Journal of the Association of Avian Veterinarians 218-225.

      [10] Crook M (2006), Clinical chemistry & metabolic medicine: Hodder Arnold London.

      [11] Doumas BT & Biggs HG (1972), Determination of serum globulins. In: Cooper GR, editor. Standard Methods of Clinical Chemistry. New York, NY: Academic Press. p 175.

      [12] Ehmeza N, Elmajdoub A, Abusnina A, Bennour E, Elhafi G & El-Mahmoudy A (2016), Comparative safety profiles of two enrofloxacin generics after repeated intracrop administration to broilers. International Journal of Biological Research 4, 170-176.

      [13] Fossati P & Prencipe L (1982), Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clinical Chemistry 28, 2077-2080.

      [14] Fraschini F, Scaglione F & Demartini G (1993), Clarithromycin clinical pharmacokinetics. Clinical Pharmacokinetics 25, 189-204.

      [15] Jacks S, Giguere S, Gronwall R, brown M & Merritt K (2002), Disposition of oral clarithromycin in foals. Journal of Veterinary Pharmacology and Therapeutics 25, 359-362.

      [16] Krieg M, Gunsser K, Steinhagen-Thiessen E & Becker H (1986), Comparative quantitative clinico-chemical analysis of the characteristics of 24-hour urine and morning urine. Journal of clinical chemistry and clinical biochemistry Zeitschrift fur klinische Chemie und klinische Biochemie 24, 863-869.

      [17] Marshall W (1988), Plasma proteins. Illustrated textbook of clinical chemistry. In: londres: gower Medical Publishing.

      [18] Ohtani H, Taninaka C, Hanada E, Kotaki H, Sato H, Sawada Y & Iga T (2000), Comparative pharmacodynamic analysis of QT interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats. Antimicrobial Agents and Chemotherapy 44, 2630-2637.

      [19] Olayinka E & Ore A (2012), Administration of Clarithromycin (Claricin®) Induces Changes in Antioxidant Status and Biochemical Indices in Rats. Research Journal of Pharmacology 6, 52-61.

      [20] Rodvold KA (1999), Clinical pharmacokinetics of clarithromycin. Clinical Pharmacokinetics 37, 385-398.

      [21] Schmidt F (1961), Enzymatic determination of glucose and fructose simultaneously. Klinische Wochenschrift 39, 1244-1247.

      [22] Tietz NW (1995), Clinical guide to laboratory tests WB Saunders. Philadelphia, PA.

      [23] Xie S, Wang F, Wang Y, Zhu L, Dong Z, Wang X, Li X & Zhou W (2011), acute toxicity study of tilmicosin-loaded hydrogenated castor oil-solid lipid nanoparticles. Particle and fibre toxicology 8, 1-10.




Article ID: 6689
DOI: 10.14419/ijbr.v4i2.6689

Copyright © 2012-2015 Science Publishing Corporation Inc. All rights reserved.